UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 2.040

Sortiert nach

Cross-Reacting Antibodies Enhance Dengue Virus Infection in Humans

Science (American Association for the Advancement of Science), 2010-05, Vol.328 (5979), p.745-748

2010

Volltextzugriff (PDF)

Influence of mutations in hepatitis B virus surface protein on viral antigenicity and phenotype in occult HBV strains from blood donors

Journal of hepatology, 2012-10, Vol.57 (4), p.720-729

2012

Volltextzugriff (PDF)

Development of a recombinant tetravalent dengue virus vaccine: Immunogenicity and efficacy studies in mice and monkeys

Vaccine, 2010-03, Vol.28 (15), p.2705-2715

2010

Volltextzugriff (PDF)

A recombinant measles vaccine expressing chikungunya virus-like particles is strongly immunogenic and protects mice from lethal challenge with chikungunya virus

Vaccine, 2013-08, Vol.31 (36), p.3718-3725

2013

Volltextzugriff (PDF)

A novel therapeutic cytomegalovirus DNA vaccine in allogeneic haemopoietic stem-cell transplantation: a randomised, double-blind, placebo-controlled, phase 2 trial

The Lancet infectious diseases, 2012-04, Vol.12 (4), p.290-299

2012

Volltextzugriff (PDF)

Polyethyleneimine is a potent mucosal adjuvant for viral glycoprotein antigens

Nature biotechnology, 2012-09, Vol.30 (9), p.883-888

2012

Volltextzugriff (PDF)

Human Immunodeficiency Virus Type 1 V1-V2 Envelope Loop Sequences Expand and Add Glycosylation Sites over the Course of Infection, and These Modifications Affect Antibody Neutralization Sensitivity

Journal of Virology, 2006-10, Vol.80 (19), p.9586-9598

2006

Volltextzugriff (PDF)

B-Cell Responses During Primary and Secondary Dengue Virus Infections in Humans

The Journal of infectious diseases, 2011-11, Vol.204 (10), p.1514-1522

2011

Volltextzugriff (PDF)

Safety and Immunogenicity of an AS01-adjuvanted Varicella-zoster Virus Subunit Candidate Vaccine Against Herpes Zoster in Adults ≥ 50 Years of Age

The Journal of infectious diseases, 2013-12, Vol.208 (12), p.1953-1961

2013

Volltextzugriff (PDF)

Vaccine Prevention of Maternal Cytomegalovirus Infection

The New England journal of medicine, 2009-03, Vol.360 (12), p.1191-1199

2009

Volltextzugriff (PDF)

Impact of hepatitis B virus (HBV) preS/S genomic variability on HBV surface antigen and HBV DNA serum levels

Hepatology (Baltimore, Md.), 2012-08, Vol.56 (2), p.434-443

2012

Volltextzugriff (PDF)

A West Nile Virus Recombinant Protein Vaccine That Coactivates Innate and Adaptive Immunity

The Journal of infectious diseases, 2007-06, Vol.195 (11), p.1607-1617

2007

Volltextzugriff (PDF)

CD4+ T-cell responses to herpes simplex virus type 2 (HSV-2) glycoprotein G are type specific and differ in symptomatic and asymptomatic HSV-2-infected individuals

Journal of general virology, 2004-08, Vol.85 (8), p.2139-2147

2004

Volltextzugriff (PDF)

Targeting of envelope domain III protein of DENV type 2 to DEC-205 receptor elicits neutralizing antibodies in mice

Vaccine, 2013-05, Vol.31 (19), p.2366-2371

2013

Volltextzugriff (PDF)

Better Neutralization of Herpes Simplex Virus Type 1 (HSV-1) Than HSV-2 by Antibody From Recipients of GlaxoSmithKline HSV-2 Glycoprotein D2 Subunit Vaccine

The Journal of infectious diseases, 2014-08, Vol.210 (4), p.571-575

2014

Volltextzugriff (PDF)

The transmembrane proteins contribute to immunodeficiencies induced by HIV-1 and other retroviruses

AIDS (London), 2014-05, Vol.28 (8), p.1081-1090

DENNER, Joachim

2014

Volltextzugriff (PDF)

Profile and Persistence of the Virus-Specific Neutralizing Humoral Immune Response in Human Survivors of Sudan Ebolavirus (Gulu)

The Journal of infectious diseases, 2013-07, Vol.208 (2), p.299-309

2013

Volltextzugriff (PDF)

Hepatitis C Virus E2 Has Three Immunogenic Domains Containing Conformational Epitopes with Distinct Properties and Biological Functions

Journal of Virology, 2004-09, Vol.78 (17), p.9224-9232

2004

Volltextzugriff (PDF)

Role of molecular mimicry of hepatitis C virus protein with platelet GPIIIa in hepatitis C–related immunologic thrombocytopenia

Blood, 2009-04, Vol.113 (17), p.4086-4093

2009

Volltextzugriff (PDF)

Additional Glycosylation Within a Specific Hypervariable Region of Subtype 3a of Hepatitis C Virus Protects Against Virus Neutralization

The Journal of infectious diseases, 2013-12, Vol.208 (11), p.1888-1897

2013

Volltextzugriff (PDF)

Pediatric measles vaccine expressing a dengue tetravalent antigen elicits neutralizing antibodies against all four dengue viruses

Vaccine, 2010-09, Vol.28 (41), p.6730-6739

2010

Volltextzugriff (PDF)

HCV glycoprotein E2 is a novel BDCA-2 ligand and acts as an inhibitor of IFN production by plasmacytoid dendritic cells

Blood, 2012-11, Vol.120 (23), p.4544-4551

2012

Volltextzugriff (PDF)

Glycoprotein B Vaccine Is Capable of Boosting Both Antibody and CD4 T-Cell Responses to Cytomegalovirus in Chronically Infected Women

The Journal of infectious diseases, 2011-06, Vol.203 (11), p.1534-1541

2011

Volltextzugriff (PDF)

Effects of a SARS-associated coronavirus vaccine in monkeys

The Lancet (British edition), 2003-12, Vol.362 (9399), p.1895-1896

2003

Volltextzugriff (PDF)

Vaccine-Induced Cross-Genotype Reactive Neutralizing Antibodies Against Hepatitis C Virus

The Journal of infectious diseases, 2011-10, Vol.204 (8), p.1186-1190

2011

Volltextzugriff (PDF)

1 – 25 von 2.040

Suche als RSS-Feed

Aktive Filter

ThemaMedical Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.999)
Mit Volltextzugriff
(1.661)

Publikationsform

Artikel
(2.040)

Sprache

Englisch
(2.040)
Japanisch
(250)
Portugiesisch
(1)

Erscheinungsjahr

n.n

Thema

Biological And Medical Sciences
(2.040)
Science & Technology
(1.893)
Life Sciences & Biomedicine
(1.866)
Infectious Diseases
(1.698)
Humans
(1.625)
Viral Diseases
(1.455)
Human Viral Diseases
(1.311)
Virology
(1.168)
Immunology
(1.087)
Microbiology
(955)
Aids/hiv
(816)
Fundamental And Applied Biological Sciences. Psychology
(816)
Female
(752)
Viral Envelope Proteins - Immunology
(729)
Viral Diseases Of The Lymphoid Tissue And The Blood. Aids
(687)
Animals
(659)
Male
(608)
Human Immunodeficiency Virus 1
(560)
Molecular Sequence Data
(542)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Cross-Reacting Antibodies Enhance Dengue Virus Infection in Humans

Influence of mutations in hepatitis B virus surface protein on viral antigenicity and phenotype in occult HBV strains from blood donors

Development of a recombinant tetravalent dengue virus vaccine: Immunogenicity and efficacy studies in mice and monkeys

A recombinant measles vaccine expressing chikungunya virus-like particles is strongly immunogenic and protects mice from lethal challenge with chikungunya virus

A novel therapeutic cytomegalovirus DNA vaccine in allogeneic haemopoietic stem-cell transplantation: a randomised, double-blind, placebo-controlled, phase 2 trial

Polyethyleneimine is a potent mucosal adjuvant for viral glycoprotein antigens

Human Immunodeficiency Virus Type 1 V1-V2 Envelope Loop Sequences Expand and Add Glycosylation Sites over the Course of Infection, and These Modifications Affect Antibody Neutralization Sensitivity

B-Cell Responses During Primary and Secondary Dengue Virus Infections in Humans

Safety and Immunogenicity of an AS01-adjuvanted Varicella-zoster Virus Subunit Candidate Vaccine Against Herpes Zoster in Adults ≥ 50 Years of Age

Vaccine Prevention of Maternal Cytomegalovirus Infection

Impact of hepatitis B virus (HBV) preS/S genomic variability on HBV surface antigen and HBV DNA serum levels

A West Nile Virus Recombinant Protein Vaccine That Coactivates Innate and Adaptive Immunity

CD4+ T-cell responses to herpes simplex virus type 2 (HSV-2) glycoprotein G are type specific and differ in symptomatic and asymptomatic HSV-2-infected individuals

Targeting of envelope domain III protein of DENV type 2 to DEC-205 receptor elicits neutralizing antibodies in mice

Better Neutralization of Herpes Simplex Virus Type 1 (HSV-1) Than HSV-2 by Antibody From Recipients of GlaxoSmithKline HSV-2 Glycoprotein D2 Subunit Vaccine

The transmembrane proteins contribute to immunodeficiencies induced by HIV-1 and other retroviruses

Profile and Persistence of the Virus-Specific Neutralizing Humoral Immune Response in Human Survivors of Sudan Ebolavirus (Gulu)

Hepatitis C Virus E2 Has Three Immunogenic Domains Containing Conformational Epitopes with Distinct Properties and Biological Functions

Role of molecular mimicry of hepatitis C virus protein with platelet GPIIIa in hepatitis C–related immunologic thrombocytopenia

Additional Glycosylation Within a Specific Hypervariable Region of Subtype 3a of Hepatitis C Virus Protects Against Virus Neutralization

Pediatric measles vaccine expressing a dengue tetravalent antigen elicits neutralizing antibodies against all four dengue viruses

HCV glycoprotein E2 is a novel BDCA-2 ligand and acts as an inhibitor of IFN production by plasmacytoid dendritic cells

Glycoprotein B Vaccine Is Capable of Boosting Both Antibody and CD4 T-Cell Responses to Cytomegalovirus in Chronically Infected Women

Effects of a SARS-associated coronavirus vaccine in monkeys

Vaccine-Induced Cross-Genotype Reactive Neutralizing Antibodies Against Hepatitis C Virus

Aktive Filter

Suchergebnisse filtern